Page last updated: 2024-09-03

modipafant and 2,3-dinor-thromboxane b2

modipafant has been researched along with 2,3-dinor-thromboxane b2 in 1 studies

Compound Research Comparison

Studies (modipafant)	Trials (modipafant)	Recent Studies (post-2010) (modipafant)	Studies (2,3-dinor-thromboxane b2)	Trials (2,3-dinor-thromboxane b2)	Recent Studies (post-2010) (2,3-dinor-thromboxane b2)
29	3	3	154	20	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, PJ; Carty, TJ; Chung, KF; Eskra, JD; O'Connor, BJ; Uden, S	1

Trials

1 trial(s) available for modipafant and 2,3-dinor-thromboxane b2

Article	Year
Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. American journal of respiratory and critical care medicine, 1994, Volume: 150, Issue:1 Topics: Administration, Inhalation; Administration, Oral; Airway Resistance; Bronchoconstriction; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Eicosanoids; Humans; Imidazoles; Leukocyte Count; Leukotriene E4; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Thromboxane B2	1994

Article

Year

Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.

American journal of respiratory and critical care medicine, 1994, Volume: 150, Issue:1

Topics: Administration, Inhalation; Administration, Oral; Airway Resistance; Bronchoconstriction; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Eicosanoids; Humans; Imidazoles; Leukocyte Count; Leukotriene E4; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Thromboxane B2

1994